Precision BioSciences shares are trading lower after HC Wainwright maintained a Buy rating on the stock but lowered its price target from $5 to $3.
Portfolio Pulse from Benzinga Newsdesk
Precision BioSciences' shares are trading lower after HC Wainwright maintained a Buy rating on the stock but lowered its price target from $5 to $3.
August 17, 2023 | 3:06 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
HC Wainwright has maintained a Buy rating on Precision BioSciences but lowered its price target from $5 to $3, causing the stock to trade lower.
The lowering of the price target by HC Wainwright, despite maintaining a Buy rating, indicates a less optimistic outlook for Precision BioSciences. This has led to a decrease in the stock's price as investors adjust their expectations.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100